EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease

Wen Chen, Jessica M Gullett, Rebecca E Tweedell, Thirumala-Devi Kanneganti iD

European Journal of Immunology · 2023-11 · 53 (11)

DOI: 10.1002/eji.202250235 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 03.03.2023. Verfasst von Wen Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Apoptosis, Pyroptosis. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulated cell death (RCD) triggered by innate immune activation is an important strategy for host survival during pathogen invasion and perturbations of cellular homeostasis. There are two main categories of RCD, including nonlytic and lytic pathways. Apoptosis is the most well‐characterized nonlytic RCD, and the inflammatory pyroptosis and necroptosis pathways are among the best known lytic forms. While these were historically viewed as independent RCD pathways, extensive evidence of cross‐talk among their molecular components created a knowledge gap in our mechanistic understanding of RCD and innate immune pathway components, which led to the identification of PANoptosis. PANoptosis is a unique innate immune inflammatory RCD pathway that is regulated by PANoptosome complexes upon sensing pathogens, pathogen‐associated molecular patterns (PAMPs), damage‐associated molecular patterns (DAMPs) or the cytokines produced downstream. Cytosolic innate immune sensors and regulators, such as ZBP1, AIM2 and RIPK1, promote the assembly of PANoptosomes to drive PANoptosis. In this review, we discuss the molecular components of the known PANoptosomes and highlight the mechanisms of PANoptosome assembly, activation and regulation identified to date. We also discuss how PANoptosomes and mutations in PANoptosome components are linked to diseases. Given the impact of RCD, and PANoptosis specifically, across the disease spectrum, improved understanding of PANoptosomes and their regulation will be critical for identifying new therapeutic targets and strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisPyroptosisCell DeathCytosolImmunity, Innate

Stichwörter der Autor:innen

ApoptosisCaspasesInflammasomeNecroptosisPANoptosisPANoptosomePyroptosis

Autor:innen und Institutionen

  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Thirumala-Devi Kanneganti

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIAMS NIH HHS

Zitieren

APA

Chen, W., Gullett, J. M., Tweedell, R. E., & Kanneganti, T. D. (2023). Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease. European Journal of Immunology, 53(11). https://doi.org/10.1002/eji.202250235

Vancouver

Chen W, Gullett JM, Tweedell RE, Kanneganti TD. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease. European Journal of Immunology. 2023;53(11). doi:10.1002/eji.202250235

BibTeX
@article{Chen2023,
  author = {Chen, Wen and Gullett, Jessica M and Tweedell, Rebecca E and Kanneganti, Thirumala-Devi},
  title = {Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease},
  journal = {European Journal of Immunology},
  year = {2023},
  volume = {53},
  number = {11},
  doi = {10.1002/eji.202250235}
}
Kostenlos starten →